Sale

Microbiome Sequencing Services Market

Global Microbiome Sequencing Services Market Report: By Products and Services: Reagents and Consumables, Instruments, Services; By Technology: Sequencing by Synthesis, Sequencing by Ligation, Shotgun Sequencing, Sanger Sequencing, Other Technologies; By Applications; By End Use; Regional Analysis; Supplier Landscape; 2024-2032

Global Microbiome Sequencing Services Market Outlook

The global microbiome sequencing services market size was valued at USD 2.17 billion in 2023, driven by the rising number of dental caries among all age groups across the globe. The market size is anticipated to grow at a CAGR of 20.6% during the forecast period of 2024-2032 to achieve a value of USD 11.72 billion by 2032.

 

Microbiome Sequencing Services: Introduction

Microbiome sequencing is a method of decoding the genetic material of all the microorganisms in a sample including bacteria, virus, fungi, and protists. There are two major methods that are used, one is whole genome shotgun sequencing (WGS), and the other one is amplicon sequencing. WGS is an unbiased method that detects all the genetic material in the sample. Amplicon sequencing targets a portion of the genetic material that is shared among the microorganisms but contains regions of variability that allow their identification. Identification of microorganisms in a sample by sequencing techniques and data analysis allows several advantages over traditional culturing approaches.

 

Global Microbiome Sequencing Services Market Analysis

The increasing demand for personalized supplements or treatments among the patients is directly influencing the market growth. The pharmaceutical companies are investing heavily in the development of more customer centric medications, such as personalized medications and supplements. For example, DSM Venturing has invested in a crop of startup Sun Genomics, which is taking advantage of the growing precision of microbiome research. The approach is expected to combine whole-genome sequencing with gut composition analysis to produce personalized supplements for each customer. The continuously ongoing explorations, heavy investments, developments of new innovative products are strongly anticipated to boost the global microbiome sequencing services market demand.

 

The increasing research and development activities to explore the potential of microbiome sequencing in body parts other than the gut has also been creating traction. There are several companies that have already begun to develop products targeting them. The increasing utilization of microbiome sequencing services towards skin is being used as basis for cosmetics.

 

Global Microbiome Sequencing Services Market Segmentations

Market Breakup by Products and Services

  • Reagents and Consumables
  • Instruments
  • Services

 

Market Breakup by Technology

  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Shotgun Sequencing
  • Sanger Sequencing
  • Pyrosequencing
  • Other Technologies

 

Market Breakup by Applications

  • Drug Development
  • Agriculture and Food Industry
  • Environmental Monitoring
  • Others

 

Market Breakup by End Use

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Microbiome Sequencing Services Market Overview

The rising number of research and development activities and clinical trials due to the increasing awareness about the potential of microbiome associated with health and diseases is a major factor driving the market growth.

 

As result of various studies, microbiome has been proven to have the ability to be used in the production of personalized medicines, which works by targeting the issue. This ability of microbiome to be used to produce personalized medicine for better patient outcomes, there has been a surge in the demand for personalized medicine in the market. The increasing demand and awareness about personalized medicines is further propelling the global microbiome sequencing services market growth.

 

The rising prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disorders, is a major factor responsible for the increased since these medical conditions may require personalized medicines for the patients depending upon their genetic arrangements.

 

There has been an interest developing recently towards exploring the potential of microbiome sequencing services in learning more about the connections between the gut and the brain health which is further expected to aid the global microbiome sequencing services market share. The expansion of microbiome sequencing services fields other than pharmaceuticals such as cosmetics are also expected to support the market expansion.

 

Microbiome Sequencing Services Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Qiagen N.V.
  • BaseClear B.V.
  • Zymo Research Corporation
  • Second Genome
  • Microbiome Insights Inc.
  • CosmosID Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Products and Services
  • Technology
  • Applications
  • End Use
  • Region
Breakup by Products and Services
  • Reagents and Consumables
  • Instruments
  • Services
Breakup by Technology
  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Shotgun Sequencing
  • Sanger Sequencing
  • Pyrosequencing
  • Other Technologies
Breakup by Applications
  • Drug Development
  • Agriculture and Food Industry
  • Environmental Monitoring
  • Others
Breakup by End Use
  •  Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Qiagen N.V.
  • BaseClear B.V.
  • Zymo Research Corporation
  • Second Genome
  • Microbiome Insights Inc.
  • CosmosID Inc.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Microbiome Sequencing Services Market Overview
 
    3.1    Global Microbiome Sequencing Services Market Historical Value (2017-2023) 
    3.2    Global Microbiome Sequencing Services Market Forecast Value (2024-2032)
4    Global Microbiome Sequencing Services Market Landscape
    4.1    Global Microbiome Sequencing Services Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Microbiome Sequencing Services Product Landscape
        4.2.1    Analysis by Product and Services
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Microbiome Sequencing Services Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Microbiome Sequencing Services Market Segmentation 
    6.1    Global Microbiome Sequencing Services Market by Products and Services
        6.1.1    Market Overview
        6.1.2    Reagents and Consumables
        6.1.3    Instruments
        6.1.4    Services
    6.2    Global Microbiome Sequencing Services Market by Technology
        6.2.1    Market Overview
        6.2.2    Sequencing by Synthesis
        6.2.3    Sequencing by Ligation
        6.2.4    Shotgun Sequencing
        6.2.5    Sanger Sequencing
        6.2.6    Pyrosequencing
        6.2.7    Other Technologies
    6.3    Global Microbiome Sequencing Services Market by Applications
        6.3.1    Market Overview
        6.3.2    Drug Development
        6.3.3    Agriculture and Food Industry
        6.3.4    Environmental Monitoring
        6.3.5    Others
    6.4    Global Microbiome Sequencing Services Market by End Use
        6.4.1    Market Overview
        6.4.2    Academic and Research Institutes
        6.4.3    Pharmaceutical and Biotechnology Companies
        6.4.4    Contract Research Organizations (CROs)
        6.4.5    Others
    6.5    Global Microbiome Sequencing Services Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Microbiome Sequencing Services Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Microbiome Sequencing Services Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Microbiome Sequencing Services Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Microbiome Sequencing Services Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Microbiome Sequencing Services Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Grants Analysis
    12.1    Analysis by year
    12.2    Analysis by Amount Awarded
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Grant Application
    12.5    Analysis by Funding Institute
    12.6    Analysis by NIH Departments
    12.7    Analysis by Recipient Organization 
13    Funding Analysis
    13.1    Analysis by Funding Instances
    13.2    Analysis by Type of Funding
    13.3    Analysis by Funding Amount
    13.4    Analysis by Leading Players
    13.5    Analysis by Leading Investors
    13.6    Analysis by Geography
14    Partnership and Collaborations Analysis
    14.1    Analysis by Partnership Instances
    14.2    Analysis by Type of Partnership
    14.3    Analysis by Leading Players
    14.4    Analysis by Geography
15    Regulatory Framework
    15.1    Regulatory Overview
        15.1.1    US FDA
        15.1.2    EU EMA
        15.1.3    INDIA CDSCO
        15.1.4    JAPAN PMDA
        15.1.5    Others
16    Supplier Landscape
    16.1    Illumina, Inc.
        16.1.1    Financial Analysis
        16.1.2    Product Portfolio
        16.1.3    Demographic Reach and Achievements
        16.1.4    Mergers and Acquisition
        16.1.5    Certifications
    16.2    Thermo Fisher Scientific, Inc.
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisition
        16.2.5    Certifications
    16.3    Pacific Biosciences of California, Inc.
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisition
        16.3.5    Certifications
    16.4    Oxford Nanopore Technologies Ltd.
        16.4.1    Financial Analysis
        16.4.2    Product Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisition
        16.4.5    Certifications
    16.5    Qiagen N.V.
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisition
        16.5.5    Certifications
    16.6    BaseClear B.V.
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisition
        16.6.5    Certifications
    16.7    Zymo Research Corporation
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisition
        16.7.5    Certifications
    16.8    Second Genome
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisition
        16.8.5    Certifications
    16.9    Microbiome Insights Inc.
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisition
        16.9.5    Certifications
    16.10    CosmosID Inc.
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisition
        16.10.5    Certifications
17    Global Microbiome Sequencing Services Market - Distribution Model (Additional Insight)
    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment 
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 2.17 billion in 2023, driven by the increasing geriatric and paediatric patient pool.

The market is anticipated to grow at a CAGR of 20.6% during the forecast period of 2024-2032, likely to reach a market value of USD 11.72 billion by 2032.

The rising chronic diseases such as diabetes and obesity among people across the globe and the rising investments by pharmaceutical companies to develop precision medicine are among the major factors driving the demand for the market.

The increasing number of studies to observe the efficacy and potential of microbiome sequencing and increasing awareness among people is a major trend influencing the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The products and services available in the market include reagents and consumables, instruments, and services.

The technologies used in microbiome sequencing include sequencing by synthesis, sequencing by ligation, shotgun sequencing, sanger sequencing, and pyrosequencing, among other technologies.

They find wide applications in drug development, environmental monitoring, agriculture and food industry, among others.

The end users in the market include academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs), among others.

Key players involved in the market are Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., Qiagen N.V., BaseClear B.V., Zymo Research Corporation, CosmosID Inc., Microbiome Insights Inc., and Second Genome.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER